Italia markets closed

22nd Century Group, Inc. (XXII)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
1,6800+0,0800 (+5,00%)
Alla chiusura: 04:00PM EDT
1,6400 -0,04 (-2,38%)
Dopo ore: 07:53PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente1,6000
Denaro1,5800 x 800
Lettera1,7500 x 800
Min-Max giorno1,5300 - 1,7409
Intervallo di 52 settimane1,4500 - 180,9600
Media Volume1.444.147
Beta (5 anni mensile)1,49
Rapporto PE (ttm)N/D
EPS (ttm)-42,2400
Prossima data utili07 mag 2024 - 13 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A720,00
  • GlobeNewswire

    22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States

    First Drug Store Channel Retail Chain Begins VLN® Sales in September, Continues to Book Additional Launches for Rest of 2023BUFFALO, N.Y., Sept. 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced its FDA authorized VLN® reduced nicotine content cigarettes designed specifically to promote tobacco h

  • GlobeNewswire

    Presenting on the Emerging Growth Conference on September 6 and 7 Register Now

    MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- a leading independent small cap media portal announces the schedule of the 62nd Emerging Growth Conference on September 6 & 7, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting com

  • GlobeNewswire

    22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets

    BUFFALO, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ: XXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company’s tobacco assets. The process will include consideration of a range of strategic, operational and financial transactions and alternatives, such as business combinations, asset sales, licensing agreements,